Research of Pathogenesis and Novel Therapeutics in Arthritis
- PMID: 30987068
- PMCID: PMC6479975
- DOI: 10.3390/ijms20071646
Research of Pathogenesis and Novel Therapeutics in Arthritis
Abstract
Arthritis has a high prevalence globally and includes over 100 types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis, but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for these patients. In this editorial, the twenty articles published in the Special Issue Research of Pathogenesis and Novel Therapeutics in Arthritis 2019 are summarized and discussed as part of the global picture of the current understanding of arthritis.
Keywords: anti-arthritis; biomarkers; osteoarthritis; rheumatoid arthritis.
Conflict of interest statement
The author declares no conflict of interest.
References
-
- Boehme K.A., Rolauffs B. Onset and progression of human osteoarthritis-can growth factors, inflammatory cytokines, or differential mirna expression concomitantly induce proliferation, ecm degradation, and inflammation in articular cartilage? Int. J. Mol. Sci. 2018;19:2282. doi: 10.3390/ijms19082282. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical